Nalaganje...

Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC) has been made over the past decade, the 5-year survival rate in patients with lung cancer remains only...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Tuberc Respir Dis (Seoul)
Main Authors: Jung, Chi Young, Antonia, Scott J.
Format: Artigo
Jezik:Inglês
Izdano: The Korean Academy of Tuberculosis and Respiratory Diseases 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5771744/
https://ncbi.nlm.nih.gov/pubmed/29332322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2017.0120
Oznake: Označite
Brez oznak, prvi označite!